Insider · CIK 0001470981

Ji Henry

Reports to the SEC for 4 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001470981

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-17	SCLXScilex Holding Co · Warrant (right to buy)S Sale	Director, Exec Chair, CEO and President	SSale	−650K sh	$0.15	−$100K	2,600,000
2026-04-16	SCLXScilex Holding Co · Warrant (right to buy)P Purchase	Director, Exec Chair, CEO and President	PPurchase	+3.25M sh	$0.15	+$500K	3,250,000
2025-10-08	SCLXScilex Holding Co · Incentive Stock Option (right to buy)A Award	Director, Exec Chair, CEO and President	AAward	+120K sh	—	—	120,000
2024-10-31	SCLXScilex Holding CoP Purchase	Director, Exec Chair, CEO and President	PPurchase	+8,888 sh	$0.94	+$8,351.165	320,161
2024-10-17	SCLXScilex Holding CoP Purchase	Director, Exec Chair, CEO and President	PPurchase	+10K sh	$0.97	+$9,710	60,070
2024-06-18	SCLXScilex Holding Co · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	Director, Exec Chair, CEO and President	MExercise/Conversion	−6,000 sh	—	—	194,000
2024-06-18	SCLXScilex Holding CoM Exercise/Conversion	Director, Exec Chair, CEO and President	MExercise/Conversion	+6,000 sh	$1.41	+$8,460	311,273
2024-05-17	SCLXScilex Holding CoP Purchase	Director, Exec Chair, CEO and President	PPurchase	+50K sh	$0.88	+$44K	50,070
2023-10-04	SCLXScilex Holding Co · Nonstatutory Stock Option (right to buy)A Award	Director, Exec Chair, CEO and President	AAward	+200K sh	—	—	200,000
2023-03-17	Sorrento Therapeutics, Inc.Put Option (obligation to buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−195 sh	—	—	0
2023-03-17	Sorrento Therapeutics, Inc.X Exercise of In-Money	Director, See Remarks	XExercise of In-Money	+19.5K sh	$0.80	+$15.7K	20,000
2023-03-17	SCLXScilex Holding CoJ Other	Director, Exec Chair, CEO and President	JOther	+2,730 sh	$8.60	+$23.5K	2,730
2023-01-17	SCLXScilex Holding Co · Nonstatutory Stock Option (right to buy)A Award	Director, Exec Chair, CEO and President	AAward	+9M sh	—	—	9,000,000
2022-12-21	Sorrento Therapeutics, Inc.Put Option (obligation to buy)X Exercise of In-Money	Director, See Remarks	XExercise of In-Money	−3 sh	—	—	195
2022-12-21	Sorrento Therapeutics, Inc.X Exercise of In-Money	Director, See Remarks	XExercise of In-Money	+300 sh	$5.50	+$1,650	500
2022-12-15	Sorrento Therapeutics, Inc.A Award	Director, See Remarks	AAward	+1.5M sh	—	—	6,265,805
2022-12-02	Sorrento Therapeutics, Inc.Put Option (obligation to buy)X Exercise of In-Money	Director, See Remarks	XExercise of In-Money	−2 sh	—	—	198
2022-12-02	Sorrento Therapeutics, Inc.X Exercise of In-Money	Director, See Remarks	XExercise of In-Money	+200 sh	$5.50	+$1,100	200
2022-09-07	Sorrento Therapeutics, Inc.Call Option (right to buy)P Purchase	Director, See Remarks	PPurchase	+759 sh	$40.66	+$30.9K	759
2022-09-07	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+88.9K sh	$2.02	+$179K	4,765,805
2022-09-07	Sorrento Therapeutics, Inc.Call Option (right to buy)P Purchase	Director, See Remarks	PPurchase	+129 sh	$41.66	+$5,374.14	129
2022-09-06	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+55.6K sh	$1.96	+$109K	4,676,917
2022-09-02	Sorrento Therapeutics, Inc.A Award	Director, See Remarks	AAward	+2.5M sh	—	—	4,621,362
2022-08-26	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+33.3K sh	$2.11	+$70.3K	2,121,362
2022-08-26	Sorrento Therapeutics, Inc.Put Option (obligation to buy)S Sale	Director, See Remarks	SSale	−200 sh	$349.33	−$69.9K	200
2022-08-25	Sorrento Therapeutics, Inc.Call Option (right to buy)P Purchase	Director, See Remarks	PPurchase	+1,000 sh	$30.66	+$30.7K	1,000
2022-08-25	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+22.2K sh	$2.06	+$45.8K	2,088,029
2022-06-14	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+10K sh	$1.40	+$14K	2,065,807
2021-09-29	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10K sh	$4.00	+$40K	2,055,807
2021-09-29	Sorrento Therapeutics, Inc.Non-qualified stock optionsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10K sh	—	—	0
2021-08-30	Sorrento Therapeutics, Inc.Stock option (right to buy)A Award	Director, See Remarks	AAward	+2.5M sh	—	—	2,500,000
2020-10-16	Sorrento Therapeutics, Inc.Non-Qualified Stock Option (right to buy)A Award	Director, See Remarks	AAward	+24.9M sh	—	—	24,935,882
2020-06-15	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director, See Remarks	AAward	+1.5M sh	—	—	1,500,000
2019-04-19	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director, See Remarks	AAward	+1.5M sh	—	—	1,500,000
2018-07-20	Sorrento Therapeutics, Inc.Common StockM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−6,000 sh	—	—	0
2018-07-20	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+6,000 sh	$1.75	+$10.5K	2,045,807
2018-05-17	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director, See Remarks	AAward	+750K sh	—	—	750,000
2018-02-28	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+64.6K sh	$9.95	+$643K	1,906,177
2018-02-28	Sorrento Therapeutics, Inc.J Other	Director, See Remarks	JOther	+124K sh	—	—	260,161
2018-01-21	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+1.8M sh	—	—	1,841,577
2018-01-21	Sorrento Therapeutics, Inc.Common Stock Warrant (right to buy)P Purchase	Director, See Remarks	PPurchase	+261K sh	—	—	261,438
2017-09-14	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director, See Remarks	AAward	+750K sh	—	—	750,000
2017-09-11	Sorrento Therapeutics, Inc.J Other	Director, See Remarks	JOther	+67.9K sh	—	—	135,863
2017-06-15	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+9,000 sh	$1.84	+$16.6K	29,001
2017-06-15	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+20K sh	$1.80	+$36K	20,001
2017-04-19	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+100K sh	$2.00	+$200K	139,776
2017-02-22	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+2,000 sh	$5.60	+$11.2K	39,776
2017-02-10	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+20K sh	$5.15	+$103K	37,776
2017-02-03	Sorrento Therapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+20K sh	$5.15	+$103K	37,776
2016-11-11	Sorrento Therapeutics, Inc.Stock OptionsJ Other	Director, See Remarks	JOther	−200K sh	—	—	300,000

Recent filings

Accepted (ET)
Apr 204
Ji Henry0001193125-26-162846
SEC(opens sec.gov)
Oct 94
Ji Henry0001193125-25-235241
SEC(opens sec.gov)
Oct 314
Ji Henry0000950170-24-119394
SEC(opens sec.gov)
Oct 184
Ji Henry0000950170-24-115449
SEC(opens sec.gov)
Jun 184
Ji Henry0000950170-24-075213
SEC(opens sec.gov)
May 174
Ji Henry0000950170-24-062009
SEC(opens sec.gov)
Oct 54
Ji Henry0000950170-23-052259
SEC(opens sec.gov)
Mar 204
Ji Henry0000899243-23-009159
SEC(opens sec.gov)
Mar 204
Ji Henry0000899243-23-009127
SEC(opens sec.gov)
Jan 174
Ji Henry0000899243-23-001866
SEC(opens sec.gov)
Dec 234
Ji Henry0001209191-22-062586
SEC(opens sec.gov)
Dec 164
Ji Henry0001209191-22-061746
SEC(opens sec.gov)
Sep 74
Ji Henry0001209191-22-049065
SEC(opens sec.gov)

Companies

Address

C/O SCILEX HOLDING COMPANY 960 SAN ANTONIO ROAD

PALO ALTO, CA, 94303